News and Announcements
Shivom Covered on David Pakman Show, Finance News Network, and ICO review
- Published April 10, 2018 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Key Takeaways:
- Shivom featured on the Finance News Network, David Pakman Show, and ICO Review
- Shivom generates a traction through its futuristic interlocking of blockchain technology and genomic data.
Shivom is creating a lot of buzz with its unique and futuristic interlocking of blockchain technology and genomic data. Recently, Shivom’s CEO Axel Schumacher and CIO Henry Ines have been featured on the Finance News Network, David Pakman Show, and ICO Review.
The videos offer insights on the project, Shivom’s ICO offering, and include interviews with Co-Founders of Shivom and their vision, respectively.
You can view the videos at:
ICO Review – https://youtu.be/u62-J7QWpMA
David Pakman show featuring Henry Ines – https://www.youtube.com/watch?
Finance News Network featuring Dr. Axel Schumacher and Henry Ines –https://www.youtube.com/watch?
These videos highlight Shivom’s prospects and its purpose of decentralising DNA and genomic data while ensuring full control and privacy to the DNA donors and genomic data providers.
Watch the Co-founding team talk to experts and explain the idea behind Shivom’s creation as they also provide a perspective on the future of precision medicine, DNA-based medical research, blockchain solutions and the importance of encrypting sensitive information DNA. In these videos, they also address concerns surrounding Shivom’s proposed use of the blockchain technology and genomic information.
We would also like to inform you that we are nearing the crowd sale event of our OmiX token which is only a few days from now.
About Shivom
Shivom combines blockchain, A.I., DNA sequencing & cryptography to enable secure and personalized medicine. The Shivom platform works on collaboration & integrity, allowing people to own, manage and monetize their data. By creating a web-marketplace, a network of genomic counsellors, and a not-for-profit drug research unit, Shivom will build a global healthcare ecosystem, reaching even low-income countries.
Company Updates
The Biofilm Breakthrough: How An Australian BioTech Firm Is Tapping Indonesia’s $45,000-a-Kitchen Bottleneck
Australian sustainability and deep-tech firm Altair International Pty Ltd is commercialising plant-based clinical hygiene technology, targeting a prime operational bottleneck in Indonesia’s massive national free meals program. Every few years, an Australian deep-tech company emerges combining proprietary science with a transformational anchor contract, the kind of business that quietly creates an entirely new market category […]
THE TAX CHANGED. NOW THE PRODUCT IS CHANGING TO MATCH.
Changes to the 50% capital gains tax discount are shifting Australian private capital away from growth and into high-yielding wrappers. Fund managers are actively redesigning products across private credit and property to capture the incoming capital rotation
The Algorithm Re-Dosing Cancer Treatment: Inside the University of Melbourne Spin-Out Rewriting a 60-Year-Old Formula
Oncology specialists are still calculating toxic chemotherapy doses using a formula from the era of the Ford Model T, leading to a system where seven out of eight patients are routinely overdosed. University of Melbourne spin-out PredicTx is dismantling this legacy approach, utilizing advanced AI to analyze existing patient CT scans, deliver precision medicine to the bedside, and return a massive 100x financial rerate to hospital networks.
Backed By Leading Investment Groups and Family Offices
